首页> 外文期刊>Genetic testing and molecular biomarkers >Cystic Fibrosis Conductance Regulator, Tumor Necrosis Factor, Interferon Alpha-10, Interferon Alpha-17, and Interferon Gamma Genotyping as Potential Risk Markers in Pulmonary Sarcoidosis Pathogenesis in Greek Patients
【24h】

Cystic Fibrosis Conductance Regulator, Tumor Necrosis Factor, Interferon Alpha-10, Interferon Alpha-17, and Interferon Gamma Genotyping as Potential Risk Markers in Pulmonary Sarcoidosis Pathogenesis in Greek Patients

机译:囊性纤维化传导调节剂,肿瘤坏死因子,α-10干扰素,α-17干扰素和γ干扰素基因分型是希腊患者肺结节病发病机制中的潜在危险指标

获取原文
获取原文并翻译 | 示例
       

摘要

Sarcoidosis is a complex disease with autoimmune basis and still unknown etiology. We have screened for mutations in the cystic fibrosis conductance regulator (CFTR) gene and genotyped single-nucleotide polymorphisms in the tumor necrosis factor (TNF), interferon alpha-10 (IFNA10), IFNA17, and interferon gamma (IFNG) genes in 89 Greek patients with sarcoidosis and 212 control subjects to detect possible association between them and the risk for developing sarcoidosis. We have found a statistically significant increase (p = 6.1 × 10~(-8)) of CFTR mutation carriers in the population of patients with sarcoidosis versus the control population. A difference was also noted within the group of patients with sarcoidosis where the ones with CFTR mutations suffered more frequently from dyspnea than those without (p = 5 × 10~(-6)). Our study did not reproduce the associations previously noted with the TNF, IFNA10, IFNA17, and IFNG genes, which highlights the genetic complexity of the disorder and is in agreement with previous studies showing that CFTR might be an important factor in the clinical course of the disease.
机译:结节病是具有自身免疫基础且病因仍未知的复杂疾病。我们在89个希腊文中筛查了囊性纤维化电导调节剂(CFTR)基因的突变和肿瘤坏死因子(TNF),干扰素α-10(IFNA10),IFNA17和干扰素gamma(IFNG)基因的基因型单核苷酸多态性结节病患者和212名对照受试者,以检测他们与结节病风险之间的可能关联。我们发现结节病患者人群中的CFTR突变携带者与对照组相比有统计学意义的增加(p = 6.1×10〜(-8))。在结节病患者组中也存在差异,CFTR突变的患者比无结节病的患者呼吸困难的发生率更高(p = 5×10〜(-6))。我们的研究没有重现先前与TNF,IFNA10,IFNA17和IFNG基因的关联,这突显了该疾病的遗传复杂性,并且与先前的研究一致,表明CFTR可能是糖尿病临床过程中的重要因素。疾病。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2010年第4期|P.577-584|共8页
  • 作者单位

    Service of Genetic Medicine University Hospitals of Geneva 1, rue Michel-Servet 1211 Geneva 4 Switzerland;

    Department of Medical Genetics, Medical School, University of Athens, Athens, Greece;

    6th Department of Respiratory Medicine, Sotiria Chest Disease Hospital, Athens, Greece;

    Department of Medical Genetics, Medical School, University of Athens, Athens, Greece;

    Department of Medical Genetics, Medical School, University of Athens, Athens, Greece;

    Department of Medical Genetics, Medical School, University of Athens, Athens, Greece;

    Department of Medical Genetics, Medical School, University of Athens, Athens, Greece;

    Department of Medical Genetics, Medical School, University of Athens, Athens, Greece;

    Critical Care Department, Evangelismos Hospital, Medical School, Athens University, Athens, Greece;

    Department of Medical Genetics, Medical School, University of Athens, Athens, Greece;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-17 13:20:24

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号